GleamWall
中文EN

VCYT VERACYTE, INC.

Services-Medical Laboratories · Nasdaq · SEC CIK 1384101 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY17.5%
TTM net income YoY318.4%
TTM EPS YoY305.3%
Revenue 3-yr CAGR19.2%
Net income 3-yr CAGR—

Margins

Gross margin72.0%
Operating margin17.1%
Net margin21.8%
FCF margin27.8%
EBITDA margin20.8%

Returns

ROE9.4%
ROA8.6%
ROIC (approx.)9.1%
Asset turnover0.40x

Leverage & solvency

Liabilities / assets8.9%
Debt / equity0.00x
Current ratio5.56x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.37x
Accruals ratio-3.2%
Payout ratio—
Capex / revenue2.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$517.14M$445.76M
Gross profit$362.53M$298.14M
R&D expense$70.81M$69.29M
SG&A expense$110.78M$110.61M
Operating income$57.78M$16.14M
Pretax income$68.20M$25.74M
Income tax$1.85M$1.61M
Net income$66.35M$24.14M
EBITDA$79.19M$39.60M
EPS (basic)0.840.32
EPS (diluted)0.820.31
Weighted avg. shares (diluted)80.57M78.16M
Balance sheet
Cash & equivalents$362.58M$240.63M
Short-term investments$50.31M—
Receivables$44.66M$46.52M
Inventory$20.55M$21.75M
Current assets$488.38M$372.27M
PP&E, net$22.19M$22.95M
Goodwill$767.15M$745.80M
Intangibles$89.15M$102.30M
Total assets$1.41B$1.30B
Current liabilities$59.94M$78.63M
Total liabilities$96.44M$124.07M
Shareholders' equity$1.31B$1.18B
Shares outstanding79.36M77.77M
Cash flow statement
Operating cash flow$136.31M$75.10M
Capital expenditure$9.68M$11.29M
Free cash flow$126.63M$63.81M
Investing cash flow-$9.21M-$56.27M
Financing cash flow-$4.22M$4.90M
Depreciation & amortization$21.41M$23.46M
Stock-based compensation$43.60M$36.25M

Free plan shows the latest 2 periods; Pro shows all 15 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.